Anzeige
Mehr »
Mittwoch, 14.01.2026 - Börsentäglich über 12.000 News
Gold auf Rekordhoch: Eine der spannendsten Gold-Stories 2026 steht ganz am Anfang
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
765 Leser
Artikel bewerten:
(1)

Antech Diagnostics: Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory

Antech to offer UK veterinary professionals a complete and flexible diagnostics portfolio spanning reference labs, in-house diagnostics, imaging and software

WARWICK, England, 7 Nov. 2023 /PRNewswire/ -- Antech, the full-service veterinary diagnostics business that is part of the Science & Diagnostics division of Mars Petcare, today announced the opening of a new UK veterinary diagnostics laboratory in Warwick on 15 November. This expands Antech's UK lab network, which also includes Southfields Veterinary Specialists Diagnostic Laboratory and the Dick White Referrals Diagnostic Laboratory.

Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory

Antech, a trusted partner in delivering veterinary diagnostics for more than 35 years, brings to the UK a complete portfolio that spans reference laboratory services, in-house diagnostics, comprehensive imaging and technology solutions, advanced telemedicine services and innovative rapid diagnostics.

Antech's UK offerings will include KeyScreen, a DNA-based GI parasite screening solution and the most advanced in veterinary medicine; AIS RapidRead, the fastest, most accurate rapid imaging technology that enables diagnosis in under ten minutes; and coming soon, Nu.Q®, a breakthrough innovation that measures nucleosomes to screen and monitor for canine cancer.

Nefertiti Greene, President, Mars Science & Diagnostics said: "At Mars Science & Diagnostics we are focused on enabling pets to live their healthiest lives through science, data and technology. We are continuing to bring this vision to life by establishing a full-service veterinary diagnostics offering in the UK, which spans reference labs, in-house diagnostics, imaging and software solutions. Our aim is to help UK veterinary care teams achieve the best pet health outcomes, in support of our purpose: A BETTER WORLD FOR PETS."

Dr. Christian M. Leutenegger, Vice President of Research and Development at Antech said: "Excellence in diagnostics enables vets to decide the best treatment approach for pets. We have brought innovative technologies and solutions backed by scientific rigour and data-driven insights to veterinary professionals for more than 35 years. We are excited to establish this new reference lab in the UK and, for the first-time, support veterinarians throughout the country with our full-service offering and most advanced technologies."

Find out more at the London Vet Show

To mark its UK launch, Antech will be at the London Vet Show 16-17 November, 2023.

Veterinary teams will have the opportunity to hear firsthand from Antech's experts, including head of clinical pathology Dr Butty Villiers and head of anatomic pathology Dr Rachel Pittaway, about the latest innovations and diagnostics developments, with an exciting programme of live educational sessions - from unravelling haemostasis testing to uncovering the "twist in the tail" with urine problems.

Antech invites attendees of the London Vet Show to find out more about their offering - and pick up a free backpack - by visiting them at stand G10.

Alternatively, more information can be found on the Antech website: http://antechdiagnostics.co.uk

About Mars Science & Diagnostics

Mars Science & Diagnostics is a division of Mars Petcare, a diverse business dedicated to one purpose: A BETTER WORLD FOR PETS. Science & Diagnostics brings together the power of leading pet health science with expertise across diagnostics, data, and technology to improve outcomes in pet health. Our veterinary diagnostics businesses include Antech, Heska, scil and SYNLAB Vet and our offering spans in-house diagnostic laboratory instruments and consumables, including rapid assay diagnostic products and digital cytology services; local and cloud-based data services; practice information management software and related software and support; reference laboratories; veterinary imaging and technology; education; and telemedicine with board-certified specialist support services. Our at-home diagnostics offering includes Whistle with smart devices to monitor pet health and Wisdom Panel, the world's most accurate pet DNA test. For 60 years, our Waltham Petcare Science Institute has been advancing science to better understand pet health.

Visit us at http://antechdiagnostics.co.uk. Follow us on Instagram, LinkedIn, and Facebook.

Photo - https://mma.prnewswire.com/media/2268012/Antech_Diagnostics.jpg
Logo - https://mma.prnewswire.com/media/2103850/Antech_Diagnostics_Logo.jpg

Antech Diagnostics Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/antech-launches-first-comprehensive-veterinary-diagnostics-offering-in-the-uk-including-a-new-state-of-the-art-reference-laboratory-301979280.html

© 2023 PR Newswire
Renditeturbo 2026 - 5 Aktien mit Potenzial
2025 neigt sich dem Ende zu, ohne klassische Jahresendrallye, aber mit einem DAX, der viele Kritiker Lügen gestraft hat. Über 21 Prozent Kursplus seit Jahresbeginn, stärker als der US-Markt. Wer hätte das noch vor Monaten erwartet?

Genau solche Entwicklungen machen den Reiz der Börse aus. Denn auch 2026 dürfte wieder alles anders kommen als gedacht. Während viele Analysten weiter steigende Kurse erwarten, rückt eine zentrale Frage in den Fokus: Wo entstehen im kommenden Jahr echte Überraschungen, und wie kann man davon profitieren?

Unser aktueller Spezialreport beleuchtet fünf Entwicklungen, mit denen kaum jemand rechnet, die aber enormes Renditepotenzial bergen. Vom Comeback der Ölwerte über unterschätzte Plattform-Aktien bis hin zur möglichen Wachablösung im KI-Sektor: Wer 2026 überdurchschnittlich abschneiden will, muss antizyklisch denken und frühzeitig Position beziehen.

Im kostenlosen Report stellen wir 5 Aktien vor, die 2026 im Zentrum solcher Wendepunkte stehen könnten. Solide bewertet, gut positioniert und mit überraschend starkem Momentum.

Jetzt kostenlos herunterladen! Bevor andere erkennen, wo die Chancen wirklich liegen!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.